Comment on: Clinical benefits of ezetimibe: absence of proof is just that

By Doggrell Sheila A  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 18, 2013-12 ,pp. : 2611-2613

Informa Healthcare

Access to resources Recommend Favorite

Ezetimibe/Simvastatin: A Guide to its Clinical Use in Hypercholesterolemia

By Lyseng-Williamson Katherine A.  

American Journal of Cardiovascular Drugs, Vol. 12, Iss. 1, 2012-02 ,pp. : 49-56

Adis International

Access to resources Recommend Favorite

Anesthetic Cardioprotection in Clinical Practice From Proof-of-Concept to Clinical Applications

By  

Current Pharmaceutical Design, Vol. 20, Iss. 36, 2014-11 ,pp. : 5706-5726

Bentham Science Publishers

Access to resources Recommend Favorite

Tolerance in the Absence of Autoantigen

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 7, Iss. 3, 2007-09 ,pp. : 203-210

Bentham Science Publishers

Access to resources Recommend Favorite

Application of Clinical Trial Simulation to Compare Proof-of-Concept Study Designs for Drugs with a Slow Onset of Effect; An Example in Alzheimer's Disease

By Lockwood Peter   Ewy Wayne   Hermann David   Holford Nick  

Pharmaceutical Research, Vol. 23, Iss. 9, 2006-09 ,pp. : 2050-2059

Springer Publishing Company

Access to resources Recommend Favorite